Are genetic vaccines the future for infectious diseases & cancer? (Rome)
Event date: 28 September 2016
In order to fight infectious diseases and cancer, our immune system has to face a number of problems, such as the immuno- logic tolerance, where immune suppression is exerted at systemic and local level. Therefore, the choice of antigens and vaccination technologies need to be exceptionally potent. A genetic vaccine is made of a DNA fragment which encodes for an antigen, administered as such (naked DNA) or embedded within an engineered viral vector. During the event, 30 partici- pants discussed the associated technologies’ clinical data obtained so far and the future of this highly innovative biotechnological field. Participants also toured the facilities of Takis Biotech. Takis Biotech
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.